logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Other Acute Pain

    FiltersReset Filters
    8 results

    • dsuvia

      (Sufentanil)
      AcelRx Pharmaceuticals, Inc.
      Usage: DSUVIA is indicated for adult patients in certified healthcare settings to manage acute pain severe enough to require opioid analgesia when alternatives are inadequate. It is not for home use, children, or extended use beyond 72 hours, and must be administered by a healthcare provider.

    • hydrocodone bitartrate and ibuprofen

      (Hydrocodone Bitartrate and Ibuprofen)
      Amneal Pharmaceuticals of New York LLC
      Usage: Hydrocodone bitartrate and ibuprofen tablets are indicated for the short-term management of acute pain severe enough to necessitate an opioid analgesic when alternative treatments are insufficient. They should be used cautiously, for the lowest effective dose and shortest duration, due to risks of addiction and adverse effects.

    • hydrocodone bitartrate and ibuprofen

      (Hydrocodone Bitartrate and Ibuprofen)
      Aurolife Pharma, LLC
      Usage: Hydrocodone Bitartrate and Ibuprofen Tablets are indicated for short-term management of acute pain severe enough to require an opioid analgesic when alternative treatments are inadequate. Use the lowest effective dosage for the shortest duration, avoiding long-term use unless necessary. Not for osteoarthritis or rheumatoid arthritis treatment.

    • ketorolac tromethamine

      (KETOROLAC TROMETHAMINE)
      Hospira, Inc.
      Usage: Ketorolac tromethamine is indicated for the short-term management (≤5 days) of moderately severe acute pain, typically in postoperative settings. It should start with intravenous or intramuscular dosing, with oral use only for continuation if necessary. The combined use is limited to 5 days to minimize adverse reactions.

    • meperidine hydrochloride

      (Meperidine Hydrochloride)
      Hikma Pharmaceuticals USA Inc.
      Usage: Meperidine Hydrochloride Tablets and Oral Solution are indicated for managing acute pain requiring opioid analgesics when alternative treatments are inadequate. Use is limited due to addiction risks and should not extend to chronic pain or prolonged periods to avoid toxicity risks from metabolite accumulation.

    • morphine sulfate

      (Morphine Sulfate)
      Hikma Pharmaceuticals USA Inc.
      Usage: Morphine Sulfate Oral Solution is indicated for managing acute and chronic pain in adults and pediatric patients aged 2 years and older when alternative treatments are inadequate. The 20 mg/mL formulation is specifically for opioid-tolerant adults. Caution is advised due to the risk of addiction and misuse.

    • morphine sulfate

      (Morphine Sulfate)
      Hikma Pharmaceuticals USA Inc.
      Usage: Morphine Sulfate Tablets are indicated for managing acute pain in patients (adults and children over 50 kg) and chronic pain in adults when alternative treatments are inadequate. Due to addiction risks, the drug should only be used when other analgesics are not tolerated or effective.

    • oxymorphone hydrochloride

      (Oxymorphone Hydrochloride)
      Aurolife Pharma, LLC
      Usage: Oxymorphone Hydrochloride Tablets are indicated for managing acute pain severe enough to necessitate an opioid analgesic when alternative treatments are inadequate. It is reserved for patients who have not tolerated or received sufficient relief from non-opioid alternatives, and long-term use is discouraged.